Results 141 to 150 of about 51,481 (307)

Pemphigus and Bullous Pemphigoid

open access: yesDeckerMed Family Medicine, 2020
Pemphigus disorders are characterized by acantholysis, whereas pemphigoid disorders are characterized by a dermal-epidermal split. Diagnosis of pemphigus or pemphigoid relies on a combination of positive anti-desmoglein or anti-collagen XVII serology, confirmatory direct immunofluorescence, and clinical features.
Aakaash Varma   +2 more
openaire   +1 more source

Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study

open access: yes
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Sören Dräger   +8 more
wiley   +1 more source

A Comprehensive Review of Novel Advances in Type 1 Diabetes Mellitus

open access: yesJournal of Diabetes, Volume 17, Issue 8, August 2025.
Novel approaches in the way of T1DM treatment. ABSTRACT Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disorder where the immune system targets and destroys insulin‐producing β‐cells in the pancreas. It generally emerges during childhood or adolescence, but individuals of any age can be affected.
Yazdan Ebrahimpour   +6 more
wiley   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJournal of General Internal Medicine, 2012
Barry, Ladizinski, Kachiu Cecelia, Lee
openaire   +2 more sources

Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid

open access: yesAustralasian Journal of Dermatology, Volume 66, Issue 5, Page e271-e278, August 2025.
ABSTRACT Background Mucous membrane pemphigoid (MMP) has a broad range of clinical manifestations, from relatively benign self‐limiting oral lesions to significant scarring (cicatrizing) of the oral, nasal and ocular tissues with severe functional impairment and morbidity.
Bronte Jeffrey   +9 more
wiley   +1 more source

Bullous Pemphigoid [PDF]

open access: yesJAMA Dermatology, 2013
Misha, Rosenbach   +2 more
openaire   +2 more sources

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

open access: yesClinical Oral Implants Research, Volume 36, Issue 8, Page 913-929, August 2025.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl   +2 more
wiley   +1 more source

Bullous Pemphigoid Antigen [PDF]

open access: bronze, 1979
Luis A. Diaz   +2 more
openalex   +1 more source

Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid

open access: yesCellular Metabolism and Related Disorders, 2019
Bullous pemphigoid (BP) is the most common type of autoimmune bullous diseases; drug-induced bullous pemphigoid is a rare variant of it. In the last decade, there is an increasing prevalence of BP, especially dipeptidyl peptidase-4 inhibitor-associated ...
Á. Kinyó
semanticscholar   +1 more source

Sensitivity of direct immunofluorescence in oral diseases : study of 125 cases [PDF]

open access: yes, 2008
Direct immunofluorescence (DIF) is widely used for the diagnosis of bullous diseases and other autoimmune pathologies such as oral lichen planus. There is no evidence in the literature on how the following variants influence the detection rate of DIF ...
Aguas, Silvia Cristina   +6 more
core  

Home - About - Disclaimer - Privacy